Autopsy report · NCT01580215
Long Term Follow up Investigation of Endobronchial Valves in Emphysema
Cause of deathSlow enrollment
“Inability to reach desired recruitment goal; Sponsor executed other RCTs”
Life of this trial
- Registered 3 months before it started.
- Ran for about 4 years 2 months before it stopped.
- 628 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Pulmonx International Sàrl
- Sponsor type
- Industry
- Conditions
- Pulmonary Emphysema
- Interventions
- Zephyr Endobronchial Valve (EBV)
- Participants
- 628
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome
“Recruitment did not meet sponsors timeline” - High-Dose Vitamin D Induction in Optic Neuritis
“inability to meet recruitment goals” - Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake
“Unable to recruit enough sample size for the RCT” - Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)
“'Sponsor decision following recruitment issues, not related to any safety concerns in the study” - Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide
“Low recruitment, sponsor withdrew funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.